Extent of Antigenic Diversity in the V3 Region of the Surface Glycoprotein,gp120, of Human Immunodeficiency Virus Type 1 Group M and Consequences for Serotyping

Human immunodeficiency virus type 1 (HIV-1) may be studied by molecular or immunological approaches. Most analyses have been performed by genetic comparison of isolates and have led to the definition of clades or subtypes within the major (M) group of HIV-1. Five subtypes (A to E) were initially identified by comparison of genomic sequences. Four new subtypes (F to I) were identified more recently. Amino acid differences in the immunogenic V3 loop between isolates have also been studied, leading to a phenetic classification of at least 14 clusters (1 to 14) of sequences (B. T. M. Korber, K. McInnes, R. F. Smith, and G. Myers, J. Virol. 68:6730–6744, 1994). In this study, we compared the antigenicity of the V3 consensus sequences defined by phylogenetic analysis to the antigenicity of those defined by phenetic analysis. We used a recently developed subtype-specific enzyme immunoassay (SSEIA) that uses the principle of blocking with an excess of peptide in the liquid phase. Two SSEIAs were performed, the first with five V3 sequences defined by phylogenetic analysis and the second with 14 V3 sequences defined by phenetic analysis. A total of 168 HIV-1 sera taken from seropositive individuals from seven different countries or regions were studied. Experimental and statistical data, including correlation matrix and cluster analyses, demonstrated associations between the genetic subtypes and phenetically associated groups. Most of these were predicted by Korber et al. (J. Virol. 68:6730–6744, 1994) by theoretical analysis. We also found that V3 sequences can be grouped into between three and five antigenically unrelated categories. Residues that may be responsible for major antigenic differences were identified at the apex of the V3 loop, within the octapeptide xIGPGxxx, where x represents the critical positions. Our study provides evidence that there is a limited number of V3 serotypes which could be easily monitored by serological assays to study the diversity and dynamics of HIV-1 strains.The diversity of human immunodeficiency virus type 1 (HIV-1) is a major problem in the development of an effective vaccine against AIDS. Many HIV-1 sequences are now available, and phylogenetic analysis resulting in a continuously developing classification into subtypes or clades is possible (45). HIV-1 isolates are classified into the M group (for major) or O group (for outlier). The O group contains only a few variants, all from a limited area of Africa (19, 27, 50). The M group includes variants responsible for the present AIDS pandemic. It contains at least five subtypes (A to E), to which have been added more recently four other subtypes (F to I) (23, 28, 34, 36, 37). Subtypes A, C, D, G, and H are common in Africa (21, 35, 37, 38). Subtype B is the most common in America and Europe (24, 26, 51). Subtype E occurs mainly in Asia (25, 30, 41), and subtype F has been detected in Brazil and Romania (3, 28, 34). These distributions are not restrictive. Subtype C is also present in Asia (India and China), and subtype G is also present in Russia (7, 12, 29). The African subtypes (A, C, and D) and the Asian subtype (E) have also been identified in North America and in European countries (9, 13, 14, 32, 48). All the subtypes are present in Africa, including B (detected in West Africa), E (Central African Republic), and F (Cameroon) (1, 35, 38). Analysis of the genetic diversity of HIV-1 is becoming more difficult due to the increasing frequency of coinfections and recombinations (15, 20, 44).Phylogenetic trees have been generated with gag, env, or tat nucleotide sequences. Shorter DNA sequences encoding the functionally important V3 region of the envelope protein are most frequently used to provide reliable subtype designations (37). The diversity of the immunogenic V3 loop has also been studied by comparing the amino acids of different isolates, leading to a phenetic classification of at least 14 clusters of sequences, each one characterized by a consensus sequence based on the most common amino acid in a given position (22).The heterogeneity of HIV-1 strains is studied mostly by molecular characterization of genomic sequences. This involves sequencing fragments amplified by the PCR or the use of the heteroduplex mobility assay (10, 11). However, although these methods allow direct subtype classification, they are time-consuming and expensive and require highly trained workers. Serotyping of HIV-1 by antibody (Ab) binding to the V3 region has been suggested as an alternative approach (8, 40, 49, 51). Such an approach may make it possible to identify subtypes based on antigenic rather than genetic properties. This immunological information about antigenic diversity might be of value in vaccine development. We recently developed a subtype-specific enzyme immunoassay (SSEIA) which gave results consistent with those of genotyping (4, 48). This assay used V3 consensus sequences defined by genetic classification, so we wanted to compare the antigenicity of these V3 consensus sequences to the antigenicity of those defined by phenetic analysis. The phenetic clustering of V3 loop amino acid sequences is not always consistent with phylogenetic analysis. Our results suggested that a limited number of serotypes may exist and identified amino acids at the tip of the V3 loop that may be responsible for serological discrimination.